| Targeting the progression of chronic kidney disease M Ruiz-Ortega, S Rayego-Mateos, S Lamas, A Ortiz, RR Rodrigues-Diez Nature Reviews Nephrology 16 (5), 269-288, 2020 | 778 | 2020 |
| Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy S Rayego-Mateos, JL Morgado-Pascual, L Opazo-Ríos, M Guerrero-Hue, ... International journal of molecular sciences 21 (11), 3798, 2020 | 258 | 2020 |
| Role of epidermal growth factor receptor (EGFR) and its ligands in kidney inflammation and damage S Rayego-Mateos, R Rodrigues-Diez, JL Morgado-Pascual, F Valentijn, ... Mediators of inflammation 2018 (1), 8739473, 2018 | 155 | 2018 |
| Targeting inflammation to treat diabetic kidney disease: the road to 2030 S Rayego-Mateos, RR Rodrigues-Diez, B Fernandez-Fernandez, ... Kidney international 103 (2), 282-296, 2023 | 153 | 2023 |
| CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-κB E Sanchez-Lopez, S Rayego, R Rodrigues-Diez, JS Rodriguez, ... Journal of the American Society of Nephrology 20 (7), 1513-1526, 2009 | 146 | 2009 |
| Statins: could an old friend help in the fight against COVID‐19? RR Rodrigues‐Diez, A Tejera‐Muñoz, L Marquez‐Exposito, ... British journal of pharmacology 177 (21), 4873-4886, 2020 | 134 | 2020 |
| Special issue “diabetic nephropathy: diagnosis, prevention and treatment” M Ruiz-Ortega, RR Rodrigues-Diez, C Lavoz, S Rayego-Mateos Journal of Clinical Medicine 9 (3), 813, 2020 | 125 | 2020 |
| Bromodomain and extraterminal proteins as novel epigenetic targets for renal diseases JL Morgado-Pascual, S Rayego-Mateos, L Tejedor, B Suarez-Alvarez, ... Frontiers in pharmacology 10, 1315, 2019 | 93 | 2019 |
| IL-17A is a novel player in dialysis-induced peritoneal damage R Rodrigues-Díez, LS Aroeira, M Orejudo, MA Bajo, JJ Heffernan, ... Kidney international 86 (2), 303-315, 2014 | 90 | 2014 |
| Protective role of Nrf2 in renal disease M Guerrero-Hue, S Rayego-Mateos, C Vázquez-Carballo, ... Antioxidants 10 (1), 39, 2020 | 85 | 2020 |
| Role of macrophages and related cytokines in kidney disease E Cantero-Navarro, S Rayego-Mateos, M Orejudo, L Tejedor-Santamaria, ... Frontiers in medicine 8, 688060, 2021 | 84 | 2021 |
| Renin-angiotensin system and inflammation update E Cantero-Navarro, B Fernandez-Fernandez, AM Ramos, ... Molecular and cellular endocrinology 529, 111254, 2021 | 81 | 2021 |
| Connective tissue growth factor is a new ligand of epidermal growth factor receptor S Rayego-Mateos, R Rodrigues-Díez, JL Morgado-Pascual, ... Journal of Molecular Cell Biology 5 (5), 323-335, 2013 | 81 | 2013 |
| Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process R Rodrigues Diez, R Rodrigues-Diez, C Lavoz, S Rayego-Mateos, ... PloS one 5 (11), e14145, 2010 | 74 | 2010 |
| Toll-like receptors in acute kidney injury C Vázquez-Carballo, M Guerrero-Hue, C García-Caballero, ... International journal of molecular sciences 22 (2), 816, 2021 | 72 | 2021 |
| RICORS2040: the need for collaborative research in chronic kidney disease A Ortiz Clinical kidney journal 15 (3), 372-387, 2022 | 71 | 2022 |
| Epigenetic modification mechanisms involved in inflammation and fibrosis in renal pathology JL Morgado-Pascual, V Marchant, R Rodrigues-Diez, N Dolade, ... Mediators of inflammation 2018 (1), 2931049, 2018 | 70 | 2018 |
| Inhibition of bromodomain and extraterminal domain family proteins ameliorates experimental renal damage B Suarez-Alvarez, JL Morgado-Pascual, S Rayego-Mateos, ... Journal of the American Society of Nephrology 28 (2), 504-519, 2017 | 70 | 2017 |
| New therapeutic targets in chronic kidney disease progression and renal fibrosis S Rayego-Mateos, JM Valdivielso Expert Opinion on Therapeutic Targets 24 (7), 655-670, 2020 | 69 | 2020 |
| Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation S Rayego‐Mateos, JL Morgado‐Pascual, RR Rodrigues‐Diez, ... The Journal of pathology 244 (2), 227-241, 2018 | 63 | 2018 |
